-- 荷蘭環保組織Milieudefensie對殼牌公司(SHEL)提起新的訴訟,試圖禁止該公司在荷蘭進行任何新的油氣開發。週二,殼牌公司發表聲明稱,Milieudefensie的訴訟「不切實際、不合理,而且從根本上就是錯誤的」。 據報道,Milieudefensie表示,殼牌必須停止鑽探新的油氣田,以減少破壞氣候的活動,並要求該公司根據《巴黎協定》在2030年至2050年間減少碳排放。 殼牌回應稱,該訴訟“忽略了油氣在未來幾十年將繼續發揮的作用”,並且“脫離了全球能源系統的現實”。 該公司表示:“隨著可再生能源的持續增長和普及,未來幾年仍需要對油氣開發進行投資,以抵消自然衰退並確保能源供應安全。” 殼牌也強調,停止油田開發並不會減少全球碳排放,因為生產權只會轉移到其他公司。 殼牌公司表示,由於資源歸各國所有,「如何開發其自然資源應由各國政府決定,而非法國環境組織Milieudefensie」。 2024年,海牙上訴法院駁回了Milieudefensie對殼牌公司的首起訴訟。該訴訟要求殼牌公司到2030年將排放量在2019年的基礎上減少45%。 今年5月,在環保組織Milieudefensie提出上訴後,海牙最高法院將審理此案。 殼牌公司表示,其油氣產量僅佔全球總產量的2%,而國營企業則貢獻了全球一半以上的產量和60%的儲量。 殼牌公司的目標是到2030年,將天然氣和上游業務的總產量每年提高1%,液體產量達到每日約140萬桶。 殼牌公司表示,該公司已在全球低碳平台領域投資約 200 億美元,並計劃根據市場需求和政府政策擴大投資組合。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.